CSMS #49912026 - Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Product Code End-date

U.S. Customs and Border Protection sent this bulletin at 10/28/2021 09:34 AM EDT

Cargo Systems Messaging Service

CSMS #49912026 - Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Product Code End-date

Due to duplication, the Food and Drug Administration (FDA) will be end-dating the Center for Drug Evaluation and Research (CDER) Product Code listed below. The product code below will be end-dated in 30 days. The end-date will be effective on November 28, 2021.

End-Dated Code/Description

64O[][]06/Pembrolizumab, Monoclonal Antibodies

Instead, please use the product code below.

Product Code/Description

62Z[][]31/Pembrolizumab (Anti-Neoplastic - Part II)

Please send any questions or concerns to the email address for the Product Code Builder Feedback: PCBFeedback@fda.hhs.gov

For assistance with product code identification, the public may also refer to the FDA Product Code Builder.

Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com.

This service is provided to you at no charge by U.S. Customs and Border Protection.

Privacy Policy | GovDelivery is providing this information on behalf of U.S. Department of Homeland Security, and may not use the information for any other purposes.